Uncategorized -
Omega Flex, Inc. Announces Election of a Director: Stephen M. Shea
EXTON, Pa., April 09, 2024 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announces that that our […]
Uncategorized -
Rogers collabore avec CableLabs afin de développer une technologie de réseau de pointe à l’intention des Canadiennes et Canadiens
CALGARY, Alberta, 09 avr. 2024 (GLOBE NEWSWIRE) — Rogers Communications a annoncé aujourd’hui sa collaboration avec CableLabs pour offrir aux […]
Uncategorized -
Rogers Collaborates with CableLabs to Develop Industry-Leading Network Technology for Canadians
CALGARY, Alberta, April 09, 2024 (GLOBE NEWSWIRE) — Rogers Communications today announced it is collaborating with CableLabs to bring the […]
Uncategorized -
Toll Brothers Announces New Luxury Home Community Coming Soon to Saline, Michigan
SALINE, Mich., April 09, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today […]
Uncategorized -
HII is Awarded $74 Million Contract to Support U.S. Navy Vertical Launch Systems
MCLEAN, Va., April 09, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Mission Technologies division was awarded […]
Uncategorized -
Beamr to enable real-time video streaming over 5G with NVIDIA Holoscan for Media
Herzliya Israel, April 09, 2024 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and […]
Uncategorized -
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
MDNA113 is targeted to the tumor site where it is activated to simultaneously deliver two immunotherapies, an IL-2 superkine and […]
Uncategorized -
Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C – ISIN Code: […]
Uncategorized -
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Major Histocompatibility Complex Class I (MHC-I) negative tumors are refractory to immune-oncology therapies, including resistance to checkpoint blockers, due to […]
Uncategorized -
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
– Preclinical data presented at AACR demonstrate that combining IMM-1-104 with chemotherapies used in the treatment of first-line pancreatic cancer […]
